Literature DB >> 12233923

Incidence of seizures in patients with multiple sclerosis: a population-based study.

Paul A Nyquist1, Gregory D Cascino, Robyn L McClelland, John F Annegers, Moses Rodriguez.   

Abstract

OBJECTIVE: To determine whether multiple sclerosis (MS) is associated with occurrence of seizure activity. PATIENTS AND METHODS: The medical records of all incidence patients with MS in Olmsted County, Minnesota, from 1935 to 1991 were reviewed. The incidence of seizures was calculated by using 3 methods: including only seizures that occurred after definite diagnosis of MS, including all seizures occurring after onset of the first symptoms of MS, and including any seizures regardless of the time of onset relative to MS. These incidences were age-adjusted to the 1970 US population and then compared with the age-adjusted incidence rate of seizures in the general population of Olmsted County.
RESULTS: The age-adjusted incidence of seizures among MS patients was not significantly higher than the age-adjusted incidence of seizures in the general population of Olmsted County. The age-adjusted incidence of first unprovoked seizures in Rochester, Minn, was 61 per 100,000 person-years. In patients with the definite diagnosis of MS, the age-adjusted Incidence was calculated at 61 per 100,000 person-years (95% confidence interval [CI], 7-114). In the group with seizures after onset of symptoms, the age-adjusted incidence rate was 80 per 100,000 person-years (95% CI, 24-135). In the group with seizures at any time in their life, the age-adjusted incidence rate was 82 per 100,000 person-years (95% CI, 41-158).
CONCLUSION: The present study does not suggest that occurrence of seizures is more common in MS patients than in the general population.

Entities:  

Mesh:

Year:  2002        PMID: 12233923     DOI: 10.4065/77.9.910

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

2.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 3.  Treatment strategies after a single seizure : rationale for immediate versus deferred treatment.

Authors:  Laura C Miller; Frank W Drislane
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

Review 5.  A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Stephen Reingold; Olaf Stuve
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

6.  Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis.

Authors:  Richard Nicholas; Roberta Magliozzi; Graham Campbell; Don Mahad; Richard Reynolds
Journal:  Mult Scler       Date:  2015-04-28       Impact factor: 6.312

7.  The prevalence of epileptic seizures in multiple sclerosis in a large tertiary hospital in Australia.

Authors:  Suyi Ooi; Tomas Kalincik; Piero Perucca; Mastura Monif
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-02-24

8.  Seizure characteristics in multiple sclerosis patients.

Authors:  Vahid Shaygannejad; Fereshteh Ashtari; Mohammad Zare; Majid Ghasemi; Rasul Norouzi; Helia Maghzi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.